Summary & Overview
CPT 83069: Urine Hemoglobin Assay
Headline: CPT code 83069: Urine Hemoglobin Assay — laboratory test for hematuria and hemoglobinuria
Lead: CPT code 83069 represents a clinical laboratory assay that quantifies hemoglobin in urine specimens to detect free hemoglobin or intact red blood cells. The test is clinically important for diagnosing hemolytic anemia, toxic exposures, infections, and other causes of urinary blood products.
Why it matters nationally: Urine hemoglobin testing is a common diagnostic tool across outpatient, emergency, and inpatient settings. Timely and accurate detection supports clinical decision-making, helps differentiate hematuria from hemoglobinuria, and can prompt further diagnostic evaluation or treatment.
Key payers covered: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare are included in the payer set for comparisons and coverage context.
What readers will learn: This publication presents benchmarks and coverage context for CPT code 83069, summarizes clinical indications and typical sites of service, and outlines common modifiers and ancillary billing considerations. It also highlights where data is available or absent for associated taxonomies, ICD-10 diagnoses, and related codes.
Scope: The content is national in scope and oriented to billing, coding, and policy audiences seeking concise clinical and administrative context for CPT code 83069.
Billing Code Overview
CPT code 83069 describes a laboratory test that measures the amount of hemoglobin in a urine specimen. The procedure detects free hemoglobin or intact red blood cells in urine and is used to identify hematuria or hemoglobinuria associated with conditions such as hemolytic anemia, toxic exposures, and urinary tract infections.
Service Type: Clinical laboratory testing (urine hemoglobin assay)
Typical Site of Service: Clinical laboratory or hospital laboratory; specimens may be collected in outpatient clinics, emergency departments, or inpatient settings
Clinical & Coding Specifications
Clinical Context
A patient presents to an outpatient or hospital laboratory for evaluation of hematuria or suspected intravascular hemolysis. Typical scenarios include: a primary care or emergency department visit for dark or discolored urine, flank pain, urinary frequency, or evaluation for hemolytic anemia after a transfusion reaction or exposure to hemolytic drugs. The clinician collects a midstream clean-catch urine specimen or a catheterized specimen and sends it to the clinical laboratory. The laboratory technologist or medical technologist performs a urinalysis with a specific test for urine hemoglobin/occult blood using a reagent strip or a quantitative spectrophotometric method to detect free hemoglobin or intact red blood cells. Results are reported in the electronic medical record and communicated to the ordering provider; findings can prompt further workup such as urine microscopy, urine culture, renal imaging, or hematology evaluation depending on whether hemoglobin is of urinary origin (hematuria) or from hemolysis (hemoglobinuria). Typical site of service: outpatient laboratory, hospital inpatient lab, emergency department, or physician office with lab services. Service type: clinical laboratory diagnostic test (urine hemoglobin/occult blood measurement).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard reporting | Used when no special circumstance applies; default billing indicator. |